Schedule 13G ownership disclosure

RedHill Biopharma Ltd.

Security class unavailable · CUSIP: M8208M118

Event date: 2019-10-17

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
69,000,010
Percent of class
13.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-22-031144
Form type
SC 13G
Filer
Cosmo Pharmaceuticals N.V.
CIK
CIK 1915527
Filed
Mar 07, 2022
Reporting period
Oct 17, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub